Lefamulin for the treatment of community-acquired pneumonia Lefamulin is a novel antibiotic with activity against many common community-acquired pneumonia (CAP) pathogens, including Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and […]